Greylin Investment Management, Inc - SOLENO THERAPEUTICS INC ownership

SOLENO THERAPEUTICS INC's ticker is SLNO and the CUSIP is 834203200. A total of 49 filers reported holding SOLENO THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.68 and the average weighting 0.1%.

Quarter-by-quarter ownership
Greylin Investment Management, Inc ownership history of SOLENO THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$103,000
-52.8%
81,795
-27.7%
0.02%
-58.8%
Q4 2020$218,000
-35.3%
113,195
-15.6%
0.05%
-43.3%
Q3 2020$337,000134,1950.09%
Other shareholders
SOLENO THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Abingworth LLP 10,302,602$9,500,0002.16%
Nantahala Capital Management 9,765,129$9,028,0000.28%
ORACLE INVESTMENT MANAGEMENT INC 2,132,000$1,971,0000.24%
Granite Point Capital Management, L.P. 701,838$649,0000.05%
OPPENHEIMER & CO INC 639,140$591,0000.01%
Ikarian Capital, LLC 121,694$112,0000.01%
Warberg Asset Management LLC 30,000$28,0000.01%
Levy Wealth Management Group, LLC 10,000$9,0000.01%
Ergoteles LLC 74,525$69,0000.00%
TWO SIGMA ADVISERS, LP 744,000$688,0000.00%
View complete list of SOLENO THERAPEUTICS INC shareholders